STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

September 29, 2025

Warning: Serious cardiovascular events don’t come out of the blue
September 29, 2025

STAT Plus: As investor for AHA, ‘Venture Valkyrie’ argues ‘good medicine is good business’
September 29, 2025

STAT Plus: Genmab to buy Merus in $8B deal
September 29, 2025

An insurance company is introducing a new threat to American medicine
September 29, 2025

STAT Plus: MoonLake can’t spin away this disastrous autoimmune drug failure
September 29, 2025

STAT Plus: AstraZeneca to list shares in New York while keeping London listing

Marking a decade of reporting from the frontiers of health and medicine

Explore STAT's story

STAT Plus: Perimenopause is the new buzzword in the business of women’s health

Perimenopause brings real symptoms and a booming market of supplements, apps, and therapies. What’s hype, what’s helpful, and what women need to know

Biotech September 29, 2025

STAT Plus: Top FDA drug regulator’s unusual criticism of a therapy gets Wall Street wagging

Neurotransmissions September 29, 2025

STAT Plus: The way we talk about dementia is about to change completely

Pharma September 29, 2025

STAT Plus: GSK CEO Walmsley to step down, be succeeded by company’s commercial lead

Opinions+ September 29, 2025

STAT Plus: Lilly executives: How the FDA’s new PreCheck program can unleash the future of U.S. medicine manufacturing

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: Unsealed court documents reveal a whistleblower suit over UnitedHealth use of an artery disease test

STAT Plus: MoonLake can’t spin away this disastrous autoimmune drug failure

STAT Plus: Child dies after receiving new experimental gene therapy

STAT Plus: Trump’s Tylenol warning cited a Harvard dean’s research. But a judge called his shifting conclusions ‘unreliable’

STAT Plus: Harvard public health school confronts severe financial crisis, seeks corporate sponsors

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2025 STAT Summit

Boston, MA

Join us October 15–16, 2025, as STAT brings the year’s biggest newsmakers to the stage to explore the future of health and medicine.

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

2025 Edition: Ranking Biotech's Top Venture Capital Firms

$499

Dive into the performance of leading biotech venture capital firms and find out who got the best returns this year.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

Our opinion podcast discusses the people, issues, and ideas that are shaping health care.

Color Code

Our podcast raising the alarm on racial inequities in American health care.

More From STAT

Events Trackers Reports Podcasts

More Stories

Health September 29, 2025

Warning: Serious cardiovascular events don’t come out of the blue

Health September 29, 2025

STAT Plus: As investor for AHA, ‘Venture Valkyrie’ argues ‘good medicine is good business’

Biotech September 29, 2025

STAT Plus: Genmab to buy Merus in $8B deal

First Opinion September 29, 2025

An insurance company is introducing a new threat to American medicine

Adam's Take September 29, 2025

STAT Plus: MoonLake can’t spin away this disastrous autoimmune drug failure

Pharma September 29, 2025

STAT Plus: AstraZeneca to list shares in New York while keeping London listing

Health September 28, 2025

STAT Plus: Harvard public health school confronts severe financial crisis, seeks corporate sponsors

First Opinion September 28, 2025

Celebrating mifepristone, a hero in modern abortion access, on its 25th anniversary in the U.S.

Letters to the editor September 27, 2025

STAT readers on gun silencers as public health measure, ‘lived experience,’ and more

Business September 26, 2025

STAT Plus: Unsealed court documents reveal a whistleblower suit over UnitedHealth use of an artery disease test

Health September 26, 2025

3 burning questions about the MMR vaccine, answered

Politics September 26, 2025

STAT Plus: Patients set to lose hospital care at home if government funding isn’t extended

Health Care Inc. Newsletter September 29, 2025

STAT Plus: Doctors face off with Cigna over new policy that may cut reimbursements

Pharmalot September 29, 2025

STAT Plus: Pharmalittle: We’re reading about a new GSK CEO, AstraZeneca’s stock listing, and more

Pharmalot September 26, 2025

STAT Plus: Pharmalittle: We’re reading about Trump’s drug pricing plans, pharma tariffs, and much more

Lab Dish September 26, 2025

STAT Plus: Despite the drama and hype from influencers, longevity science is making real progress

First Opinion September 26, 2025

STAT Plus: Making health care more accountable and affordable through crowdsourcing

Politics September 26, 2025

STAT Plus: How the government establishes research grant overhead rates: ‘It’s not like buying a widget’

Biotech September 29, 2025

STAT Plus: Top FDA drug regulator’s unusual criticism of a therapy gets Wall Street wagging

Opinions+ September 29, 2025

STAT Plus: Lilly executives: How the FDA’s new PreCheck program can unleash the future of U.S. medicine manufacturing

Neurotransmissions September 29, 2025

STAT Plus: The way we talk about dementia is about to change completely

First Opinion September 29, 2025

An insurance company is introducing a new threat to American medicine

Adam's Take September 29, 2025

STAT Plus: MoonLake can’t spin away this disastrous autoimmune drug failure

First Opinion September 28, 2025

Celebrating mifepristone, a hero in modern abortion access, on its 25th anniversary in the U.S.

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Sterilization, mysterious pain, and dismissive doctors: Why women turn to reversal surgery — and sometimes to RFK Jr.

By Eric Boodman

Is it ‘inevitable’ that men die more than five years earlier than women?

By Olivia Goldhill

STAT Plus: As reports of ‘AI psychosis’ spread, clinicians scramble to understand how chatbots can spark delusions

By O. Rose Broderick

STAT Plus: Tracking RFK Jr.’s promises to remake health in America

By Isabella Cueto and J. Emory Parker

How the myth that nicotine causes cancer is hurting public health

STAT Plus: Donavon Decker knew a gene therapy experiment wouldn’t help him. To help others, he still said yes

STAT Plus: Dropping hepatitis B shots for newborns would ignore history and endanger children, scientists warn

By Eric Boodman

STAT Plus: As Sarepta Therapeutics fights for Duchenne therapy, a group of patients gets left behind

STAT Plus: Crinetics wins FDA approval for acromegaly drug, faces competition with Novartis and Ipsen

Biotech September 25, 2025

STAT Plus: Crinetics wins FDA approval for acromegaly drug, faces competition with Novartis and Ipsen

Biotech September 24, 2025

STAT Plus: Acadia Pharmaceuticals drug for rare genetic condition fails late-stage study

Biotech September 24, 2025

STAT Plus: Experimental gene therapy for Huntington’s markedly slowed disease progression in key trial

STAT Plus: Pharmalittle: We’re reading about a PBM makeover plan, a Bristol cash-pay plan, and much more

Pharmalot September 25, 2025

STAT Plus: Pharmalittle: We’re reading about a PBM makeover plan, a Bristol cash-pay plan, and much more

Pharma September 25, 2025

STAT Plus: From an elixir for ‘little hotheads’ to deadly overdoses, how Tylenol became a medicinal scapegoat

Pharmalot September 24, 2025

STAT Plus: Global health groups push to make cheap generic versions of an HIV prevention drug sold by Gilead

A new Ebola outbreak in Congo kills dozens as health officials warn of lack of funds

Health September 25, 2025

A new Ebola outbreak in Congo kills dozens as health officials warn of lack of funds

Health September 25, 2025

STAT Plus: Autistic moms feel shamed and stigmatized by Trump’s Tylenol warning

Health September 24, 2025

STAT Plus: Trump’s ‘tough it out’ to pregnant women meets wave of opposition by medical experts

STAT Plus: Federal judge vacates rule that would have ramped up Medicare Advantage audits

Politics September 25, 2025

STAT Plus: Federal judge vacates rule that would have ramped up Medicare Advantage audits

Politics September 23, 2025

STAT Plus: With Trump’s anti-vaccine comments, Kennedy’s influence grows

Politics September 23, 2025

STAT Plus: In dispensing advice on Tylenol and autism, Trump takes on a new role: doctor in chief

Video

STAT reporters break down Trump’s announcement on Tylenol, autism and vaccines

STAT Plus: What is happening at the CDC?

STAT Plus: How AI scribes could usher in higher medical bills

STAT Plus: Deconstructing RFK Jr.’s explanation for the cancellation of mRNA vaccine contracts

ALS

ALS

STAT Plus: Inside NYU’s AI-powered plan to catch osteoporosis with repurposed CT scans

Health tech September 25, 2025

STAT Plus: Inside NYU’s AI-powered plan to catch osteoporosis with repurposed CT scans

Health tech September 24, 2025

STAT Plus: 6 groups vying to lead the charge on health AI standards

Health tech September 24, 2025

STAT Plus: Large breast cancer screening trial will be pivotal step in vetting AI for mammograms

STAT Plus: As the U.S. dials back mRNA research, the U.K. tries to seize an opportunity

In the Lab September 25, 2025

STAT Plus: As the U.S. dials back mRNA research, the U.K. tries to seize an opportunity

In the Lab September 18, 2025

STAT Plus: Despite fear of retaliation, hundreds of federal workers urge Congress to protect medicine and science

In the Lab September 17, 2025

Amid a crackdown on DEI, a group of Black neuroscientists celebrates its growth

STAT Plus: Hospitals nab $4 billion in extra Medicaid funds, before Republican cuts take effect

Hospitals July 25, 2025

STAT Plus: Hospitals nab $4 billion in extra Medicaid funds, before Republican cuts take effect

Hospitals June 16, 2025

STAT Plus: Senate GOP proposes steeper cuts to Medicaid funding in tax cut bill

Hospitals June 14, 2025

STAT Plus: Hospitals would be hit hardest by Medicaid cuts in GOP tax bill, report finds

STAT Plus: Here’s who will be hit with higher premiums if ACA enhanced subsidies expire

Insurance September 18, 2025

STAT Plus: Here’s who will be hit with higher premiums if ACA enhanced subsidies expire

Insurance September 17, 2025

STAT Plus: Major health insurer group says members will continue to cover vaccines, a step that may ease anxiety over access

Insurance September 9, 2025

STAT Plus: CMS delays rule requiring Medicare Advantage insurers to remind members of unused benefits

Podcasts

A gene therapy success in Huntington’s and Trump’s autism announcement

Pharma sours on the U.K., plus biotech M&A’s quiet roll

Trump, Chinese biotech, and an industry career reshaped by illness

New stakes in the vaccine dispute and a boost for biotech